The QualityStocks Daily Stock List
- Adynxx, Inc. (ADYX)
- Lion One Metals Limited (LOMLF)
- Meso Numismatics, Inc. (MSSV)
- Park City Group, Inc. (PCYG)
- Resverlogix Corp. (RVXCF)
- Star Navigation Systems Group Ltd. (SNAVF)
- Tel-Instrument Electronics Corp. (TIKK)
- H-Cell Energy Corporation (HCCC)
- American Rebel Holdings, Inc. (AREB)
- Green Cures and Botanical Distribution, Inc. (GRCU)
- Manhattan Scientifics, Inc. (MHTX)
- hopTo, Inc. (HPTO)
- Applied Minerals, Inc. (AMNL)
- Elcora Advanced Materials Corp. (ECORF)
Adynxx, Inc. (ADYX)
Street Insider, Investing.com, BioCentury, TipRanks, TMXmoney, Xconomy, Stockhouse, Market Screener, PR Newswire, TradingView, Stockopedia, Dividend Investor, and GlobeNewswire reported beforehand on Adynxx, Inc. (ADYX), and we also report on the Company, here at the QualityStocks Daily Newsletter.
A clinical stage biopharmaceutical company, Adynxx, Inc. focuses on bringing to market novel, disease-modifying products for the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including inflammatory and neuropathic pain. In essence, Adynxx is a leader in transcription factor decoy technology. Established in 2007, Adynxx is based in San Francisco, California. The Company’s shares trade on the OTC Markets’ OTCQB.
Adynxx has worked since its establishment to discover and develop transcription factor decoys to modify the course of pain, to collaborate with discovery partners, and to identify in-licensing opportunities with transformative therapeutic profiles to build a pipeline in pain and inflammation. It is collaborating with twoXAR to use twoXAR’s artificial intelligence-driven drug discovery platform. This is to identify endometriosis treatments. Furthermore, Adynxx is evaluating in-licensing opportunities with transformative therapeutic profiles to treat pain and inflammation.
The AYX platform employs a proprietary technology of non-opioid, disease-modifying transcription factor decoys. AYX decoys are short DNA molecules, or oligonucleotides. They selectively inhibit transcription factors controlling the genes involved in the maintenance of pain. Consequently, a single administration of an AYX decoy generates a strong, long-term reduction of pain and associated clinical benefits.
Clinical studies suggest that a single administration of brivoligide at the time of surgery can safely reduce pain for weeks, accelerate the time to achieve mild pain and substantially reduce the need for opioid use during recovery specifically in patients at greater risk of experiencing increased and prolonged pain following surgery.
In early October, Adynxx announced the receipt of a Notice of Award for $602,516 from the National Institute on Neurological Disease and Stroke (NINDS), part of the National Institutes of Health (NIH), to support development of AYX2, Adynxx’s product candidate intended to treat chronic pain. The Company received an award from the National Institute on Drug Abuse (NIDA), part of the NIH, for up to $15 million to support clinical development of its lead program brivoligide that is being studied in Phase 2 clinical trials for postoperative pain.
AYX2 is a non-opioid product candidate in development for the treatment of chronic pain resulting from numerous causes or origins. This includes inflammatory pain and neuropathic pain. The second product candidate originating from the Adynxx AYX platform, AYX2 is a transcription factor decoy targeting the activity of specific members of the Krüppel-like (KLF) family of transcription factors: KLF6, KLF9 and KLF15.
Adynxx, Inc. (ADYX), closed Friday's trading session at $1.52, up 20.396%, on 1,000 volume with 11 trades. The average volume for the last 3 months is 2,009 and the stock's 52-week low/high is $0.719099998/$31.4400005.
Lion One Metals Limited (LOMLF)
Stock Pulse, Junior Mining Network, Streetwise Reports, Geology for Investors, Mining News Feed, Mining.com, Proactive Investors, OTC Markets, Market Screener, Investor Ideas, Dividend Investor, Stockhouse, Wallet Investor, 4-Traders, InvestorsHub, TradingView, and MarketWatch reported earlier on Lion One Metals Limited (LOMLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Lion One Metals Limited engages in the acquisition, exploration, and evaluation of mineral resources in Fiji and Australia. The Company is set to become the premier high grade gold producer in the South Pacific Island nation of Fiji at its 100 percent owned and fully permitted Tuvatu Alkaline Gold Project. The Tuvatu gold deposit is situated on the island of Viti Levu in Fiji. Lion One Metals has its corporate headquarters in Vancouver, British Columbia. The Company lists on the OTCQX.
Lion One Metals envisages a low-cost, high-grade underground gold mining operation at Tuvatu coupled with exploration upside inside its tenements encompassing the entire Navilawa Caldera. This is an underexplored, highly prospective 7km diameter alkaline gold system.
The mineral resource for Tuvatu as disclosed in the technical report "Tuvatu Gold Project PEA", dated June 1, 2015, and prepared by Mining Associates Pty Ltd of Brisbane Qld, consists of 1,120,000 tonnes indicated at 8.17 g/t Au (294,000 oz. Au) and 1,300,000 tonnes inferred at 10.60 g/t Au (445,000 oz. Au) at a cut-off grade of 3 g/t Au. Tuvatu is the largest undeveloped gold project in Fiji. In addition, it is one of the highest grade gold projects anywhere in the world; centered on building production of 100,000 oz. per year over ten years.
Lion One Metals holds a 13,619 hectare exploration license package covering the entire Navilawa volcano, with the Tuvatu mining lease at its center. The area surrounding the Tuvatu Alkaline gold deposit, resource area, and underground is covered by a 3.85 km² Special Mining Lease (SML 62), with the wider project area covered by 13,619 hectare Special Prospecting Licenses (SML’s 1283, 1296, 1412 & 1465), including the Navilawa license area acquired in November of 2017.
At the beginning of October, Lion One Metals announced the commencement of its high-grade feeder diamond drill program at its Tuvatu Alkaline Gold Project in Fiji. The first drill hole, TD01, is an 800m long hole designed to target down dip extensions near the center of the present resource in an area where an extremely high-grade feeder structure appears to be coalescing.
Nearby drill hole TUDDH-160 intersected 1,614 g/t Au over 0.50m within a broader interval of 367 g/t over 2.92m, from 333m down hole depth. A second planned hole, TD02, is 1,000m long and targets a further 300m downdip below TD01. Two additional planned holes, TD03 and TD04, each 1000 m long, will test down dip areas 200m north and 200m south of TD02, respectively.
Lion One Metals Limited (LOMLF), closed Friday's trading session at $0.671, off by 0.549866%, on 96,889 volume with 37 trades. The average volume for the last 3 months is 51,458 and the stock's 52-week low/high is $0.244100004/$0.790000021.
Meso Numismatics, Inc. (MSSV)
RedChip, OTC Dynamics, TeleTrader, Last10k, TipRanks, Street Insider, Nasdaq, Simply Wall St, Investing.com, Financial Buzz, Dividend Investor, Otc.watch, InvestorsHub, MarketWatch, Stockwatch, Investors Hangout, GlobeNewswire, New Media Wire, Stockhouse, Wallet Investor, and TradingView reported earlier on Meso Numismatics, Inc. (MSSV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Meso Numismatics, Inc. is a technology and numismatic company specializing in the Meso Region, including Central America and the Caribbean. It has become the primary hub for rare, exquisite, and valuable inventory from the Meso Region and worldwide. The Company was previously known as Pure Hospitality Solutions, Inc. It changed its name to Meso Numismatics, Inc. as a result of its merger with Meso Numismatics, Corp. in September of 2018. Meso Numismatics has its head office in Boca Raton, Florida.
Meso Numismatics is the only Company in the Central American-Caribbean region that is an on-the-ground registered dealer with the Numismatic Guaranty Company (NGC) and the Paper Money Guaranty (PMG). The Company has a selection of rare inventory, and also has a specialized App for banknote recognition, available on Google Play and the Apple App Store. Meso continues to partner with some of the largest auction houses internationally for the sale of the Company’s rarer inventory.
Meso Numismatics was established in September 2016 by a group of devoted coin collectors and currency seekers from the Mesoamerica area - from Mexico to Panama. The Company specializes in this area of the region. Moreover, Meso also has inventory and clients from all over the world. Numismatics is the study or collection of currency. This includes coins, tokens, paper money, as well as related objects.
In September, Meso Numismatics announced that it has preliminarily completed the due diligence phase of the Green Pay acquisition and is now set to proceed with an audit of Green Pay to be performed by the Company’s independent registered accounting firm. According to Management, Meso’s counsel will soon begin preparing the definitive purchase agreement for the Green Pay acquisition.
Afterward, the expectation is that Meso Numismatics will issue shares of its Preferred Stock as an initial payment for the acquisition. Following that, its U.S. independent registered accounting firm will start to audit Green Pay’s financials, preparing them to be included in Meso’s SEC filings at some later date.
At present, Green Pay hosts 110 independent stores located around Central America; processes around $2.5M in monthly transactions among all of its users; and executes roughly 500,000 transactions per month. Green Pay also has approximately 400,000 monthly active users; and has about 650,000 registered credit cards representing multiple payment institutions around Central America.
Meso Numismatics, Inc. (MSSV), closed Friday's trading session at $0.025, off by 10.7143%, on 30,990 volume with 3 trades. The average volume for the last 3 months is 33,968 and the stock's 52-week low/high is $0.011199999/$0.148499995.
Park City Group, Inc. (PCYG)
Zacks, AI Stock Finder, Infront Analytics, Investing.com, Stockhouse, Stocks Equity, EarningsCast, Market Screener, TradingView, Nasdaq, GlobeNewswire, TMX Money, InvestorsHub, and Simply Wall St reported previously on Park City Group, Inc. (PCYG), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Park City Group, Inc. is a Software-as-a-Service (SaaS) provider that brings visibility to the consumer goods supply chain through its wholly-owned ReposiTrak, Inc. subsidiary. ReposiTrak is The Speed Retail Platform, with three product families. These are Compliance & Risk Management, Supply Chain Solutions, and MarketPlace Sourcing and B2B Commerce. The Company chiefly serves multi-store retail chains, wholesalers and distributors, and suppliers. Park City Group is based in Murray, Utah and lists on the NasdaqGS.
Park City Group has been helping customers for over 18 years with B2B Vendor Connections, Item & Cost Maintenance, Scan-based Trading, Invoicing from POS or Delivery, Vendor Scorecarding, Reporting & Analytics, Out-Of-Stock & Waste Reporting, and Forecasting & Ordering (Store-level & DC). ReposiTrak was originally co-founded with Leavitt Partners, led by Mr. Michael Leavitt, former Secretary of Health & Human Services, to address the expected rise in regulatory requirements associated with the Food Safety Modernization Act of 2011 (FSMA).
The ReposiTrak platform provides retailers and suppliers with a strong solution suite to help enhance operational control and increase sales. This is while enabling them to protect their brands, reduce risk and remain in compliance with regulatory requirements. ReposiTrak is a compliance, supply chain, and e-commerce platform. ReposiTrak partners with retailers, wholesalers, and their suppliers, to increase sales, control risk, as well as improve supply chain efficiencies.
Park City Group’s platform is the only completely integrated sourcing, compliance, and supplier & item management platform on the market. All of the Company’s capabilities are accessible via a cloud-based portal that consists of the ReposiTrak Speed Retail Platform.
Last week, ReposiTrak, Inc. announced The Orchards Gourmet Nuts, Candies and Gifts LLC (Wrens, Georgia) chose the ReposiTrak Compliance & Risk Management Solution to automate document compliance to address food safety regulations and support its food safety quality certification efforts. The Orchards provides gourmet nuts, candies, confections, snacks and gifts to retailers and wholesalers. In addition, it sells its products online and at a showroom store housed in its Wrens candy factory. The Orchards adopted ReposiTrak because the company needed an automated system for handling food safety government regulations and meeting Safe Quality Food (SQF) certification requirements.
Park City Group, Inc. (PCYG), closed Friday's trading session at $5.42, up 0.743494%, on 5,448 volume with 97 trades. The average volume for the last 3 months is 47,216 and the stock's 52-week low/high is $4.76000022/$9.25.
Resverlogix Corp. (RVXCF)
Stock News Now, Investor Village, Street Insider, Market Wire News, GlobeNewswire, Market Screener, OTC Markets, Investors Hangout, Dividend Investor, InvestorsHub, Investing.com, Nasdaq, Morningstar, Wallet Investor, 4-Traders, Stockhouse, MarketWatch, and TMXmoney reported beforehand on Resverlogix Corp. (RVXCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Resverlogix Corp. is a late-stage clinical biotechnology company committed to improving the lives of patients with chronic illnesses. It provides novel science, clinical and value-based health solutions to key stakeholders including pharmaceutical, physician, and health payer groups. The Company is a pioneer in the landscape of epigenetics. Apabetalone is now being evaluated in a Phase 3 clinical trial – BETonMACE – for the treatment of high-risk cardiovascular disease patients, who also have type 2 diabetes mellitus and low levels of high-density lipoprotein. Resverlogix is headquartered in Calgary, Alberta.
Full results from Resverlogix’s Phase 3 Clinical Trial – BETonMACE, studying lead drug candidate Apabetalone – will be presented during a late breaking session at AHA on November 16, 2019. Resverlogix remains centered on three initial indications – acute coronary syndrome, vascular cognitive dementia and chronic kidney disease.
Apabetalone is a BET inhibitor for the reduction of mace. Apabetalone is the world leader in a new class of drugs designed to regulate disease-associated proteins. Through inhibiting the action of bromodomain and extraterminal domain (BET) proteins, Apabetalone positively affects manifold disease-causing biological processes – leading a new paradigm shift in the treatment of chronic disease. As a selective inhibitor of the BET family of proteins, Apabetalone has the ability to normalize dysregulated epigenetics, which lie at the core of numerous chronic diseases.
At the end of September, Resverlogix announced that BETonMACE did not meet the primary endpoint – reduction in major adverse cardiovascular events (MACE), defined as cardiovascular death, non-fatal myocardial infarction and stroke – added to standard of care in high-risk patients with type 2 diabetes, recent acute coronary syndrome, and low HDL cholesterol. Apabetalone demonstrated tolerability and safety.
Mr. Donald McCaffrey, President and Chief Executive Officer of Resverlogix, said, “We are proud as a Company to be developing Apabetalone and explore its potential to reduce cardiovascular events in patients at high risk. I believe the results from BETonMACE will be a key stepping stone to advance this novel therapy to address unmet medical need and we will continue to advance our programs moving forward.”
Resverlogix Corp. (RVXCF), closed Friday's trading session at $1.10, off by 2.6549%, on 39,965 volume with 54 trades. The average volume for the last 3 months is 83,515 and the stock's 52-week low/high is $0.089905001/$4.13999986.
Star Navigation Systems Group Ltd. (SNAVF)
All Stocks Today, Hot Stocked, OTC Markets, Financial Buzz, TradingView, Research Pool, Micro Small Cap, InvestorX, Street Insider, Wallet Investor, TMX Money, 4-Traders, TradingView, Stockhouse, GlobeNewswire, and Stockwatch reported previously on Star Navigation Systems Group Ltd. (SNAVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Star Navigation Systems Group Ltd. owns the exclusive worldwide license to its proprietary, patented In-flight Safety Monitoring System, STAR-ISMS®, the core of the STAR-A.D.S. ® and of the STAR-ISAMM™ Systems. The Company develops, markets, and promotes In-Flight Safety Monitoring Systems (ISMS) globally. Its real-time capability of tracking performance trends and predicting incident-occurrence enhances aviation safety and improves fleet management. It does so while lessening costs for the operator. Star Navigation Systems is headquartered in Brampton, Ontario and lists on the OTCQB.
Subsidiary, Star-Isoneo, Inc., is a specialized software firm. Star-Isoneo develops complex solutions in engineering, simulation and development for Canadian customers. Star-Isoneo works closely with Star Navigation Systems in the development of the Company’s MEDEVAC (STAR-ISAMM™ and STAR- LSAMM™) applications of the patented STAR-A.D.S. ® technology, and on its current research and development (R&D) program with Bombardier.
Stars’ M.M.I. Division designs and manufactures high performance, mission critical, flight deck flat panel displays for defence and commercial aviation industries all over the world. As examples, these displays are found on aircraft and simulators, from C-130 aircraft, to Sikorsky and Agusta Westland helicopters.
Star has capabilities in Flat Panel Displays and the Company offers its customers, OEMs (original equipment manufacturers) and operators, advanced, reliable and proven technologies to modernize their aircraft, helicopters and other vehicles. Star’s technologies support commercial and military aviation, search and rescue operations, and naval applications.
Concerning Commercial and Military Aircraft: STAR-A.D.S.™, imbedded in the Company’s systems is global real time tracking for safer aircraft operations, and meeting today the recommendations of ICAO, IATA, NTSB for the future of Aircraft Tracking and Safety. Regarding Medical Evacuation Vehicles, applied to Emergency Medical Services vehicles and environment and MEDEVAC platforms, STAR-A.D.S.™ will ensure real time transmission of vital bio data for quick and safer dispatch and support to patients.
Last month, Star Navigation Systems announced that it entered into a partnership and industrial agreement with ANTAZ Technologies Pvt. Ltd. Antaz is a well-established Indian company with facilities in Hyderabad, Bangalore and Delhi, India. Antaz will adapt, integrate and market STAR products to the Indian Defence Forces (Air Force and Navy) in collaboration with Hindustan Aeronautics Limited (HAL). STAR is already listed as a registered supplier to HAL for military equipment.
This month, Star Navigation Systems announced the granting of a new Supplemental Type Certification (STC) to the Company by Transport Canada. The STC relates to the use of the STAR-A.D.S. ® Gen 3 system on an Airbus A320 aircraft type. The STC will allow Star to install its STAR-A.D.S. ® Gen 3 System on-board the next available AlMasria Universal Airlines aircraft.
Star Navigation Systems Group Ltd. (SNAVF), closed Friday's trading session at $0.0248, even for the day, on 24,000 volume. The average volume for the last 3 months is 2,281 and the stock's 52-week low/high is $0.017/$0.0643.
Tel-Instrument Electronics Corp. (TIKK)
Whale Wisdom, Stock Twits, Zacks, Simply Wall St, Infront Analytics, Investors Hangout, Business Wire, Whale Wisdom, Stockopedia, MarketBeat, TradingView, Investing.com, and Market Screener reported earlier on Tel-Instrument Electronics Corp. (TIKK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Tel-Instrument Electronics Corp. is the industry leader in developing and producing field-tested, robust avionic flight line and bench test sets for demanding military and commercial customers. The OTCQB-listed Company designs, manufactures, and sells avionics test and measurement solutions. These are for the commercial air transport, general aviation, and government/military aerospace and defense markets in the United States and worldwide. Established in 1947, Tel-Instrument Electronics is based in East Rutherford, New Jersey.
The Company operates in two segments, Avionics Government and Avionics Commercial. It operates in the Aerospace & Defense industry in the Industrials sector. Tel-Instrument Electronics is ISO-9001:2015 quality certified. It is compliant to ESD standard ANSI/ESD S20.20 and its products have received CE certification for sales into Europe.
Tel-Instrument Electronics’ products have led the avionics support equipment industry to higher levels of integration through combining more test functions into a single unit. This reduces customer acquisition, training, as well as life-cycle support costs. The Company provides instruments to test, measure, calibrate, and repair a range of airborne navigation and communication equipment. Furthermore, its products include TS-4530A, an identification friend or foe test set; T-47/M5, a dual crypto test set; and AN/ARM-206, an intermediate level TACAN test set.
Additionally, Tel-Instrument Electronics offers AN/USM-708 and AN/USM-719, which are communications/navigation radio frequency avionics flight line testers; TR-220, a test set that provides test capability for traffic and collision avoidance systems (TCAS), distance measuring equipment, and transponders; TR-36, a commercial navigation and communication test set that provides ramp testing; and TR-420, a ramp test set to test the operation of transponders and interrogators.
Tel-Instrument also provides multifunction ramp test sets under the T-47NC, T-47NH, and T-47G names. Moreover, the Company provides TR-100AF, a rugged ramp test used to verify airborne TACAN equipment; and AN/APM-480A, a transponder, interrogator, and TCAS test set.
Last month, Tel-Instrument Electronics reported a Mode 5 test set order of $535k from the U.S. military. This brings bookings to date for Q2 to $4.6 million and orders for the last 12 months to $19.4 million. Mr. Jeffrey O’Hara, President and Chief Executive Officer of Tel-Instrument Electronics, stated, “Bookings have improved substantially over the last year reflecting a combination of strong U.S. DoD orders as well as growing international demand for our Mode 5 test sets.”
At the beginning of October, Tel-Instrument Electronics announced that quotation of its common stock on the OTCQB was approved , effective as of the opening of the market on October 1, 2019. Immediately before October 1, 2019, its common stock had been quoted on OTC Pink.
Tel-Instrument Electronics Corp. (TIKK), closed Friday's trading session at $3.05, off by 1.6129%, on 1,073 volume with 2 trades. The average volume for the last 3 months is 3,123 and the stock's 52-week low/high is $2.20000004/$6.00.
H/Cell Energy Corporation (HCCC)
Financial Buzz, OTC Markets, Street Insider, Morningstar 4-Traders, Stockwatch, Uptick Newswire, Marketbeat, Market Screener, Simply Wall St, Stockhouse, and Wallet Investor reported previously on H/Cell Energy Corporation (HCCC), and we also report on the Company, here at the QualityStocks Daily Newsletter.
H/Cell Energy Corporation designs and implements clean energy solutions featuring hydrogen and fuel cell technology. The Company is an integrator that centers on the design and implementation of clean energy solutions. This includes solar, battery, fuel cell and hydrogen generation systems. By way of its subsidiaries, it also provides environmental systems and security systems integration. OTCQB-listed, H/Cell Energy is based in Dallas, Texas.
H/Cell serves the residential, commercial, as well as government sectors. It has developed and implemented a hydrogen energy system used to completely power a residence or commercial property with clean energy. This is so it can run independent of the utility grid and also provide energy to the utility grid for monetary credits. This inventive system utilizes renewable energy as its source for hydrogen production.
The HC-1 system is totally scalable. Upon installation, the HC-1 system operates as a self-sustaining energy system providing electricity and/or hydrogen fuel for transportation.
The design of the HC-1 system is to provide clean energy for a better environment. The system eliminates the electric bill and dependence on fossil fuels. Furthermore, this system allows one to benefit with tax and energy credits while helping make the environment safe for future generations. H/Cell Energy’s completed systems include the De Tiberge Property in Pennington, New Jersey and the Strizki Property in Hopewell, New Jersey.
Recently, H/Cell Energy announced that it entered into an equity purchase agreement with GHS Investments LLC (GHS). This agreement will provide the Company access to capital over a 24 month period.
Mr. Andrew Hidalgo, H/Cell Energy Chief Executive Officer, said, "We are very pleased to come to terms with GHS. We have reviewed many proposals for equity investments over the last year, most of which were unsuitable. However, we found GHS to be professional, competent and flexible in constructing an equity investment arrangement that we believe is beneficial to our shareholders. We intend to use any proceeds for growth initiatives as we continue to focus on building shareholder value.”
H/Cell Energy Corporation (HCCC), closed Friday's trading session at $0.392, up 30.6667%, on 5,000 volume with 3 trades. The average volume for the last 3 months is 2,252 and the stock's 52-week low/high is $0.25/$1.60000002.
American Rebel Holdings, Inc. (AREB)
Wallet Investor, Market Screener, OTC Markets, Stockwatch, Trading View, Dividend Investor, Penny Stock Hub, Capital Cube, Investors Hangout, Stocks News Feed, Street Insider, Simply Wall St, Morningstar, 4-Traders, Barchart, Wallmine, and MarketWatch reported previously on American Rebel Holdings, Inc. (AREB), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
American Rebel Holdings, Inc. is positioning itself as America's Patriotic Brand. It engages in developing diverse products in the self-defense and patriotic product areas. The Company centers on designing, manufacturing, and marketing concealed carry backpacks under the American Rebel brand name. Mr. Charles A. "Andy" Ross founded the Company as America's Patriotic Brand. American Rebel Holdings has its corporate headquarters in Nashville, Tennessee. The Company lists on the OTC Markets’ OTCQB.
American Rebel’s first product offering is its line of concealed carry products. These were launched at the 2017 NRA (National Rifle Association) Annual Meeting. The design of the Company’s products is to give one the tools needed to defend and protect oneself, their family and more. The Cartwright Concealed Carry Coat by American Rebel is featured in the third installment of a five-part series in the NRA Publication America's 1st Freedom on how to choose the proper handgun to carry for defensive purposes.
This year, American Rebel Holdings is expanding its product offerings to include Large Floor Gun Safes, Wall Safes, as well as Personal Safes. Mr. Andy Ross, American Rebel Chief Executive Officer (CEO), said, "American Rebel products keep you concealed and safe inside and outside the home."
American Rebel Safes will protect one’s firearms and valuables from theft, fire, natural disasters and in a place only appropriate members of the household can access. Mr. Nathan Findley, who comes to American Rebel Holdings with more than 10 years' experience in the outdoor and firearms industries, will lead American Rebel's expansion in gun safes.
Recently, American Rebel reported sales four times greater than 2018 at the NRA Great American Outdoor Show in Harrisburg, Pennsylvania from February 2-10, 2019. The Company said that the Cartwright Concealed Carry Coats and Cartwright Concealed Carry Backpacks were the top sellers during the trade show. These were followed by the Men's Freedom Jackets. American Rebel CEO Mr. Andy Ross appeared on a recent edition of MoneyTV to report the strong results.
American Rebel Holdings, Inc. (AREB), closed Friday's trading session at $0.498, up 42.2857%, on 40,850 volume with 8 trades. The average volume for the last 3 months is 2,812 and the stock's 52-week low/high is $0.150000005/$1.04999995.
Green Cures & Botanical Distribution, Inc. (GRCU)
Penny Stock Tweets, InvestorsHub, OTC Markets, Business Insider, ClayTrader, Stockopedia, Barchart, GuruFocus, StockGoodies, Capital Cube, Zacks, Front Page Stocks, Simply Wall St, MarketWatch, Stockhouse, Marketwired, Investors Hangout, and Daily Marijuana Observer reported on Green Cures & Botanical Distribution, Inc. (GRCU), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Green Cures & Botanical Distribution, Inc. (GRCU) is a hemp-infused nutrition, botanical, sports, and body care products business. The Company operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. GRCU is continually creating and introducing products that promote a healthy life style. Listed on the OTC Markets, the Company is based in California.
GRCU announced this past April the expansion of its corporate offices into a new space located in Woodland Hills, California. Also, the Company has received approval from California for GRCU's newest manufacturing plant. The plant had been approved for recreational manufactory and sales in the State of California.
GRCU is currently Web-based. The Company’s focus is on online retailing. Its products are branded under the Original Hollywood Hemp™ brand. Furthermore, it develops beverages branded under the Iconic Beverages ™ name.
Original Hollywood Hemp™ is hemp activated health, beauty, skin care, hair care, spices, fashion, food products and beverages with the active ingredients of hemp. Iconic Beverages™ consists of hemp infused and no hemp infused beverages. Iconic Beverages™ will feature iconic celebrities with exclusive licenses owned by GRCU and its shareholders.
GRCU announced in February 2018 that it signed a four-year agreement with Humboldt Cannabis AF in California to produce licensed cannabis and CBD products. Humboldt Cannabis AF is a cannabis and CBD company in Humboldt, California.
GRCU will look to products to be sold at retail/dispensary. Nevertheless, the Company will rely on Humboldt Cannabis AF for CBD product development. Humboldt has a track record producing top of the line, exclusively pristine product.
In addition, vibrant packaging design for the new GRCU product lines has been finalized. GRCU products are being packaged in their new, striking, provocative, Must Have Packages.
Moreover, GRCU provides online community portals. These sites supply the public with information and resources concerning the benefits of cannabis-derived products.
Green Cures & Botanical Distribution, Inc. (GRCU), closed Friday's trading session at $0.0021, up 5.00%, on 966,088 volume with 13 trades. The average volume for the last 3 months is 4,110,894 and the stock's 52-week low/high is $0.001099999/$0.009999999.
Manhattan Scientifics, Inc. (MHTX)
SmallCapVoice, Xtremepicks, The Penny Play, FeedBlitz, Hawk Associates, StockHotTips, BullRally, OurHotStockPicks, AllPennyStocks, and HotStockChat reported earlier on Manhattan Scientifics, Inc. (MHTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Manhattan Scientifics, Inc. concentrates on the commercialization of disruptive technologies in the nano-medicine space. The OTCQB-listed Company is currently developing commercial medical prosthetics applications for its ultra-fine grain metals. Its goal is to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, (now Imagion Biosystems), its wholly-owned subsidiary. Manhattan Scientifics is based in New York, New York. The Company has an office in Albuquerque, New Mexico, and Montreal, Quebec.
Manhattan Scientifics has expertise in licensing from the national laboratories (the Los Alamos National Laboratory (LANL) and the Sandia National Laboratory (SNL)). Sandia National Laboratories is a multi-mission laboratory operated by National Technology and Engineering Solutions of Sandia LLC, a wholly-owned subsidiary of Honeywell International Inc., for the U.S. Department of Energy’s National Nuclear Security Administration.
Manhattan Scientifics has an agreement to collaborate with The University of Texas M.D. Anderson Cancer Center (MDACC) to advance, demonstrate, and validate an innovative technology developed by Mr. Edward R. Flynn, PhD, for the very early detection of cancer. The Company has delivered its pioneering cancer measurement instrument to MDACC.
Manhattan Scientifics focuses on technology transfer and commercialization of transformative technologies in the nano medicine space. The Company creates Intellectual Property (IP) portfolios and business cases supporting new technologies. It guides them to relationships with industrial partners who are well-prepared to launch product.
The Company’s technology uses iron oxide nanoparticles and a technique it calls Magnetic Relaxometry to locate and measure cancers with a sensitivity that would provide a diagnosis years before other known methods.
Currently, Manhattan Scientifics is centering on nanoparticle-based cancer detection via Senior Scientific. Moreover, it is focusing on nanostructured metals technology via wholly-owned subsidiary Metallicum, Inc.
Senior Scientific has formed a research collaboration with Weill Cornell Medicine. For this alliance, it will bring its magnetic relaxometry technology to Weill Cornell Medicine. Scientists will investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers.
Manhattan Scientifics is also working on the start of product trials on its cancer detection product. The nanostructured metals technology has been revenue producing for some years. The cancer detection technology can detect cancer years earlier.
Manhattan Scientifics started as a technology incubator. Early in its history, the Company worked on acquiring a number of technologies in the fields of holographic data storage, water purification, alternative energy, advanced computer haptics and currently, nanotechnology. The Company’s chief source of latent commercial technologies are the U.S. government laboratories in New Mexico.
Manhattan Scientifics, Inc. (MHTX), closed Friday's trading session at $0.0161, up 38.7931%, on 3,432,223 volume with 41 trades. The average volume for the last 3 months is 445,766 and the stock's 52-week low/high is $0.003/$0.037999998.
hopTo, Inc. (HPTO)
Tiny Gems, Money Morning, Marketbeat.com, Wall Street Mover, SmallCapVoice, TopPennyStockMovers, and PennyStocks24 reported earlier on hopTo, Inc. (HPTO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
hopTo, Inc. is a developer of application publishing software and a mobile productivity workspace platform. The hopTo mobile solution delivers a first-rate user experience without compromising enterprise security. It delivers a mobile experience that changes the way one works and lives without any compromises or boundaries. The Company is a Citrix Ready® Premier Partner. hopTo is headquartered in Concord, New Hampshire.
The hopTo mobile solution enables one to completely embrace a mobile lifestyle. hopTo brings a new standard of mobile productivity with custom, touch enabled access to existing Windows applications and documents. hopTo are developers of application software. This includes application virtualization software and cloud computing software for multiple computer operating systems. This includes Windows, UNIX, and a number of Linux-based variants.
hopTo Work enables customers to rapidly transform their legacy applications to become touch friendly on modern mobile devices. Moreover, hopTo worked during 2015 and 2016 to integrate hopTo Work with certain software products offered by Citrix Systems.
The Company’s application publishing software solutions sell under the brand name GO-Global. GO-Global is an application access solution for use and/or resale by independent software vendors (ISVs), corporate enterprises, governmental and educational institutions, and others who desire to leverage cross-platform remote access and Web-enabled access to their existing software applications, as well as those who are installing secure, private cloud environments.
This past November, hopTo announced its financial results for Q3 ended September 30, 2017. For Q3 2017, Revenue was $1.026 million; Net Profit was $254,000; and Basic and Diluted Earnings per Share was $0.03.
Total Revenue for the first nine months of Fiscal Year 2017 was $2.93 million. This represents an increase of about 2.4 percent from $2.86 million for the same period in 2016. This revenue is entirely from hopTo’s GO-Global products and services.
For the first nine months of 2017, hopTo reported a Net Profit of $87,000 or $0.01 per basic and diluted share. This is in comparison with a Net Loss of $1.87 million or $0.19 per basic and diluted share from the same period last year.
Jean-Louis Casabonne, hopTo’s interim Chief Executive Officer, said, "The GO-Global business continues to generate positive cash flow and remains a critical aspect of the company. The GO-Global business has now shown modest growth year over year for both the three and nine month periods ended September 30, 2017 strengthening our belief that it will operate profitably in the future. Early in the third quarter, we completed a sale of seven of our fifty-three granted patents which has further improved the cash position of the Company. This sale included a license back to hopTo for those patents."
hopTo, Inc. (HPTO), closed Friday's trading session at $0.248, up 22.288%, on 2,353 volume with 1 trade. The average volume for the last 3 months is 5,021 and the stock's 52-week low/high is $0.150000005/$0.460000008.
Applied Minerals, Inc. (AMNL)
Wall Street Resources and Real Pennies reported on Applied Minerals, Inc. (AMNL), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Applied Minerals, Inc., through its ownership of the historic Dragon Mine deposit, is the foremost international producer of Dragonite™ halloysite clay and Amiron™ advanced natural iron oxides. The Company’s products address the global need for high performance, eco-friendly solutions for an array of industrial applications. Listed on the OTCQB, Applied Minerals is based in New York, New York.
The Company’s Dragonite™ is a versatile Halloysite product grade. It has a broad assortment of applications. It is an advanced reinforcing filler.
Applied Minerals’ Dragonite-XR™ product grade provides innovative advantages versus other reinforcing fillers, including glass fiber, mica, wollastonite or talc. The Company’s Dragonite-HP™ is a high-performance additive for engineering thermoplastics used at loadings of only 1-3 percent. It provides first-rate mechanical performance and cycle time reduction.
Furthermore, its Dragonite-PureWhite™ is the highest purity Dragonite™ product. It meets the strict specifications of the cosmetic industry.
Applied Minerals launched its AMIRON line of advanced natural iron oxide pigments to the construction, wood coatings, paints, industrial coatings, plastics and rubber markets in 2014. Halloysite is an aluminosilicate clay. It exhibits a rare, naturally occurring hollow tubular structure.
The Company serves the traditional halloysite markets for use in technical ceramics and catalytic applications. Applied Minerals is the leading producer of Halloysite clay and advanced, ultra-pure natural iron oxide solutions –consisting of hematite and goethite - from its wholly-owned Dragon Mine property in the State of Utah.
The Company has also developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints, coatings and building materials, environmental remediation, agricultural applications, and high-performance additives & fillers for plastic composites.
Recently, Applied Minerals announced it entered into an Exploration Agreement with Option to Purchase with Continental Mineral Claims (CMC) for metallic minerals believed to be at depths considerably below its present and future halloysite and iron oxide operations at the Dragon Mine.
With this Agreement, CMC was granted an exclusive, 10-year license by Applied Minerals to conduct exploration activities for metallic minerals at Applied Minerals' Dragon Mine property in the Tintic District of Utah. The Agreement contains protections in favor of Applied Minerals against unreasonable interference of its present and future halloysite and iron oxide mining operations.
CMC is a wholly-owned subsidiary of a private, globally recognized minerals exploration and mining company. Today, Applied Minerals updated shareholders and the marketplace on halloysite-based lithium-ion (Li-ion) battery technology. The Company has moved closer to commercialization of its Dragonite® Halloysite Clay for use in Lithium-Ion Battery Technologies.
Its main goal has been to combine its breadth of knowledge of halloysite with publicly available applied research to pursue the commercialization of Dragonite halloysite clay within select applications, which offer attractive economic opportunities. To capitalize on research that demonstrates the value of halloysite for use in Li-ion battery technologies, Applied Minerals is pursuing the commercialization of Dragonite as a value-added material to this market.
Mr. Andre Zeitoun, President and Chief Executive Officer of Applied Minerals, said, "We believe our DRAGONITE halloysite clay products, over the near-term, will provide performance enhancing solutions for existing Li-ion battery technologies and, over the longer term, will contribute to the commercialization of emerging battery technologies. The interest in DRAGONITE for use in Li-ion batteries is particularly strong among companies based in China, where the great majority of battery manufacturers reside and where the government is providing significant funding support for the majority of the battery research being utilized today."
Applied Minerals, Inc. (AMNL), closed Friday's trading session at $0.0223, up 31.1765%, on 12,000 volume with 4 trades. The average volume for the last 3 months is 42,100 and the stock's 52-week low/high is $0.010099999/$0.100000001.
Elcora Advanced Materials Corp. (ECORF)
InvestorIntel reported previously on Elcora Advanced Materials Corp. (ECORF), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Elcora Advanced Materials Corp. has been designed to become a vertically integrated (from mine to product) graphite & graphene company, which mines, processes, refines graphite, and produces the graphene and end user graphene applications. The Company has developed a unique low cost-effective process to make high quality graphite and graphene that are commercially scalable. Elcora Advanced Materials is based in Bedford, Nova Scotia. The Company lists on the OTC Markets’ OTCQB.
Elcora Advanced Materials is targeting high-end graphite applications (Li-ion batteries, graphene production & coating). It acquired the full operational control and a 40 percent equity interest in Sakura Graphite (PVT) Limited, operators of the Ragedara mine in Sri Lanka. Sri Lanka graphite is very high quality with many unique properties. This graphite is suitable for use in numerous high-end graphite applications.
Elcora has secured high-grade graphite and graphene precursor graphite from its interest in the operation of the Ragedara mine in Sri Lanka. This mine is already in production. Currently, the mine yields about 500 tonnes each year.
The Company developed its own unique graphite refining process. The process does not require the use of acids or alkaline systems. Environmentally friendly, the process yields higher quality graphite that has not been oxidized and will withstand high temperatures.
Elcora announced in April 2017 that it is building a state-of-the-art Lithium Ion (Li-ion) battery research and development laboratory in Halifax, Nova Scotia. The lab will concentrate on quality control and developing the Company’s graphite anode powder for Li-ion batteries.
Graphite powder will be routinely tested employing industry standard cells. This is to ensure the coulombic efficiency, reversible capacity, first-cycle loss and rate capabilities of the product are within Elcora’s specifications.
Recently, Elcora Advanced Materials announced that it is working with a number of battery manufacturers in Asia that are testing the Company’s graphite anode powder. Elcora has so far sent more than14 kgs of its EL-I-C6 graphite anode powder to battery manufacturers to test its electrochemical performance.
The purpose of this testing is to demonstrate that the Company’s EL-I-C6 graphite anode powder meets Li-ion battery manufacturing standards. After more testing, Elcora Advanced Materials hopes to enter into negotiations for long-term supply agreements.
Moreover, Elcora also recently announced it signed a Memorandum of Understanding (MOU) agreement with Lockheed Martin Canada. This represents Lockheed Martin's first battery technology investment in Canada.
The strategic partnership supports the increasing energy demand for Lithium-Ion battery storage solutions applied to commercial, industrial, utility, and military applications. The MOU formally creates a working relationship and guidelines to support/identify opportunities within Lockheed Martin business units; including Lockheed’s energy division to help in maximizing and attaining sales goals.
Elcora Advanced Materials Corp. (ECORF), closed Friday's trading session at $0.04, up 25.00%, on 24,000 volume with 2 trades. The average volume for the last 3 months is 14,431 and the stock's 52-week low/high is $0.032000001/$0.132400006.
The QualityStocks Company Corner
- LiveWire Ergogenics Inc. (OTC: LVVV)
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
- Xalles Holdings Inc. (OTC: XALL)
- Geyser Brands Inc. (TSX.V: GYSR)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Predictive Oncology (NASDAQ: POAI)
- Marijuana Company of America (OTCQB: MCOA)
- Nightfood Holdings, Inc. (OTCQB: NGTF)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)
- Endonovo Therapeutics Inc. (ENDV)
LiveWire Ergogenics Inc. (OTC: LVVV)
LiveWire Ergogenics Inc. (OTC: LVVV) was featured today in a publication from HempWireNews, examining how hemp growers in the Southeast region of the U.S, such as Virginia, are faced with a dry and warm growing season, which is riddled with diseases and pest pressure. Many farmers in these regions grew hemp for CBD production and flower for smoking. However, this season, their crops, especially the flowers, were attacked by corn eating worms.
LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.
During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:
PODs and Distribution in Coachella, California
For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.
Estrella Ranch in Paso Robles, California
Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.
The Paso Robles Nursery
LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.
LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.
GHC Ventures Subsidiary
GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.
GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.
LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.
LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.
7X Pure™ Dosing and Verification System
LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.
The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.
The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.
Acquisitions & Operations
To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.
Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.
The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.
LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.
LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.
Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.
As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.
Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.
Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.
Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.
Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.
Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17 Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.
LiveWire Ergogenics Inc. (OTC: LVVV), closed Friday's trading session at $0.008, off by 6.5421%, on 490,167 volume with 18 trades. The average volume for the last 3 months is 784,683 and the stock's 52-week low/high is $0.00655/$0.07.
- Highlights of Virginia’s 2019 Hemp Season
- Coverage Initiated for LiveWire Ergogenics Inc. via NetworkNewsWire
- LiveWire Ergogenics, Inc Reports Second Quarter 2019 Financial Results
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) was featured today in the 420 with CNW by CannabisNewsWire. California has made it easy for weed workers to join labor unions after Governor Gavin Newsom on Friday signed into law a bill that requires all cannabis stores that have 20 employees or more to enter into labor peace agreements.
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed Friday's trading session at $0.1239, up 3.25%, on 7,500 volume with 6 trades. The average volume for the last 3 months is 23,389 and the stock's 52-week low/high is $0.090000003/$0.578999996.
- 420 with CNW – California Marijuana Industry Workers Move to Unionize
- 420 with CNW – Marijuana Will be Legalized this Month, Says Mexican Senate Leader
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Cancellation of PCCBD Investment
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
Recreational adult-use cannabis continues to make headlines amid growing legalization throughout North America, providing opportunities for national cannabis holdings company IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) and its portfolio of premium luxury products.
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.
With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.
IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.
Elite Brand Portfolio/Acquisitions
- IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
- WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
- ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
- Vuber Technologies hardware produces the best vaporization experience on the market.
- Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
- Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.
IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.
Experienced Management Team
IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.
Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.
Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.
Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.
Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.
In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.
IONIC Brands Corp. (OTC: IONKF), closed Friday's trading session at $0.035, up 16.6667%, on 174,656 volume with 28 trades. The average volume for the last 3 months is 268,670 and the stock's 52-week low/high is $0.019999999/$0.634559988.
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Developing Edibles and Infused Beverages Amid Growth in Recreational Use Industry
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Capitalizing on Adult-Use Cannabis Industry by Anticipating Market Movement
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Reports Milestone Q2 Revenues, Completes Transformational Acquisitions
Xalles Holdings Inc. (OTC: XALL)
Xalles Holdings (OTC: XALL), a business-development company focused on the payment industry and financial technology, is developing a fintech transaction-support strategy through acquisitions and mentoring. To view the full article, visit http://ccw.fm/foCD4.
Xalles Holdings Inc. (OTC: XALL) is a fintech holding company leveraging blockchain and other technologies for e-commerce, payments, financial reconciliation, and payment auditing solutions. The company actively seeks acquisition targets with strong management teams and business models, large total attainable markets, and lucrative exit opportunities in which to invest and accelerate growth.
The common element to all acquired entities and projects is a business model that involves setting up a payment or financial transaction “toll gate,” thereby creating a recurring revenue stream.
Xalles’ business plan focuses on consumer, business and government-oriented payment and financial reconciliation transactions. Combining the blockchain decentralized financial ledger platform with the company’s existing X2X transaction reconciliation system design, Xalles is building technology that supports payment audits, exchanges, and new business models and opportunities worldwide. Xalles will launch new services card and mobile payment and rewards systems, and will expand the technology offerings for referral marketing and e-commerce engines.
All current subsidiaries are wholly owned
- Xalles Holdings
Raise capital for fintech accelerator program acquisitions, provide management, administrative, finance and marketing support to all subsidiary companies
- Xalles Capital
Management support of investment consortiums, direct investment into funds or projects, and management of investments
- Xalles Limited
Design and market new X2X solutions; acquire U.S Government transportation post-payment audit business through GSA schedule and expand to non-transportation payment auditing
- Xalles Technology
Technical development of the X2X blockchain systems
- Xalles Financial Services
Consumer and small business financial service offerings
- Co-Owners Rewards
Stock-based rewards system for payments cards and financial services
- Amazing Living Enterprises
Affiliate program and e-commerce platform for enhancing financial lives
- Global Savings Network
Not-for-profit fundraising system with consumer discounts at local merchants
Xalles provides payment and financial transaction management solutions through the company’s proprietary blockchain-based X2X technology. The X2X solution includes the Investment and Financing System (IFS), which supports complex investment structures, assists international investment consortia, and provides links to Xalles’ Financial Transaction Reconciliation (FTR) solution. FTR supports complex financial ecosystems, making it easier for parties to exchange products, services, grants and government incentives, and assists “Exchange Managers” with liquidity and auditability. X2X also supports the Xalles pre- and post-payment auditing services.
Advancements in 2019
- Co-Owners Rewards subsidiary is working to launch a general purpose reloadable prepaid payment card with a stock rewards program.
- Previously announced LYC Mortgage acquisition will create a structure that will dramatically increase revenues in 2020 with new mortgage business portfolios.
- Xalles Financial Services expects to launch the Cryptocurrency Trading Engine and acquire multiple cryptocurrency asset portfolios to drive increases in value through the trading engine.
“The structure and growth plan for the company contains a balance of diversity and synergy so that we can effectively use limited resources to obtain the best results. We will see the culmination of the fundraising efforts, acquisitions and organic growth in the second half of 2019 put us on the path to tremendous growth in 2020.”
– Xalles CEO Thomas Nash (http://nnw.fm/rU6iT)
Xalles Holdings Inc. (OTC: XALL), closed Friday's trading session at $0.0031, up 1.3072%, on 1,122,258 volume with 28 trades. The average volume for the last 3 months is 2,108,388 and the stock's 52-week low/high is $0.0013/$0.021029999.
- Xalles Holdings Inc. (XALL) Becoming Leading Provider of Payment Systems by Acquiring, Mentoring Fintech Firms
- Xalles Holdings Inc. (XALL) Enters Cryptocurrency Distribution Agreement as Fiat Money Faces Bleak Outlook
- Xalles Holdings Inc. (XALL) Targets Growing Global Account-Reconciliation Software Market
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands Inc. (TSX.V: GYSR) is a consumer wellness brand cultivator that builds and markets hemp-infused health and wellness products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, baked goods and tincture formulations with superior bioavailability and water solubility. Geyser Brands is rapidly building its revenue-generating operation with a marked milestone in September 2019 with the successful acquisition of Solace Management, a company whose portfolio includes 57 SKUs of consumer wellness goods and pet care products.
Solace recently moved into its new 7,500-square-foot GMP (Good Manufacturing Practices)-compliant facility in Coquitlam, British Columbia, which is expected to trigger up to a 10-fold increase in the company’s production capacity now that it has a Natural Health Product site license from Health Canada. Solace intends to also develop and license new products that are either ready for production or are in various stages of development, since construction of the facility is now complete.
Geyser Brands and Solace welcomed yet another marketable product to their stable with the receipt of an NPN (Natural Product Number) from Health Canada for their hemp-based pain relief roll-on, which means the pain-relief product can now be sold as a natural health product through the company’s Apothecary Naturals line. Health Canada assessed the roll-on and found it to be safe, effective and of high quality when it is used as directed.
The efficacy of most hemp products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; and provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company’s cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands’ integrated production chain and formulation lab develops innovative products using high-quality hemp for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands actively explores opportunities to invest in the research and development of unique, high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
- Apawthecary Pets – line of products has established itself as leading all-natural hemp-based pet treats with formulations for pet treats, salves and oral drops. Animals, like humans, may suffer from the insomnia, digestive difficulties, pain and inflammation hemp products are designed to relieve a wide variety of conditions. All of Apothecary’s products are made with organic, cold-pressed and unrefined hemp seed oil extract.
- Apothecary Naturals – 100% all-natural, organic, hemp-based topical products for everything from skin care to pain relief.
- WildTails – 100% all-natural, freeze-dried, single-ingredient and nano-hemp infused pet foods and treats.
- Apothecary Ink – Antibacterial skin preparation products, pain control as well as skin care for new and old tattoos.
Chairman and Co-Founder, Brad Kersch, brings a strong business background with over 20 years of experience in successful startups and working with Fortune 500 companies. He spent his early years in the advertising and marketing field and went on to form Hyperware, a clothing company that sold branded clothing to retailers across Canada before selling to clothing giant Ocean Pacific (OP). Kersch became the president of Shoreline Studios, Canada’s largest and oldest studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets.
CEO and Co-Founder, Andreas Thatcher, has been CEO of Geyser Brands since the January 2018 and has been a principal at Rhizome Group since 2014, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media investment company specializing in marketing and distribution financing, and worked in the Investment Banking industry in London and Toronto. Thatcher holds a master’s degree in economics.
CFO Gordon Clissold is a Chartered Professional Accountant with over 20 years of experience as an operational and financial manager for both public and private companies. His career experience spans multiple industries that include technology, manufacturing, wholesale distribution, and professional services. Gordon obtained his accounting designation in 1995, was awarded the Fellowship designation in 2006, and has been awarded life membership as Chartered Professional Accountant.
Kuldip Gill, head of Geyser Brands’ R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill’s experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Friday's trading session at $0.38, even for the day, on 8,500 volume with 3 trades. The average volume for the last 3 months is 2,502 and the stock's 52-week low/high is $0.349999994/$0.850000023.
- Geyser Brands Inc. (TSX.V: GYSR) Launches Luxury Hemp-Based Product Line
- YIELD GROWTH Signs Letter of Intent with Apothecary Botanicals to Manufacture and Distribute Yield's New Line of Cannabis-Infused Topicals, Jack n Jane, in Canada
- Investor Ideas Potcasts, Cannabis News and Stocks on the Move: Happy 1 Year Anniversary Canada!
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced its new strategic plan to reduce its financing requirements while maintaining its path to profitability. To view the full press release, visit http://cnw.fm/kRN5R. Also today, the company featured in a publication from HempWireNews, examining how to contribute to the research in the growing hemp industry, the state of Virginia, which is looking to revitalize the tobacco-growing region, donated $400,000 for a state testing lab for crops including hemp. Last week, researchers from Virginia Tech received a $500,000 grant from the USDA to forecast the route of wind-dispersed hemp pollen.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Friday's trading session at $0.90, off by 15.0943%, on 2,076,327 volume with 1,299 trades. The average volume for the last 3 months is 931,330 and the stock's 52-week low/high is $0.819000005/$4.38000011.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Details New Strategic Plan to Cut Financing Requirements while Preserving Path to Profitability
- Highlights of Virginia’s 2019 Hemp Season
- 420 with CNW – Former FDA Boss Calls for Federal Regulation of Marijuana Markets
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Thursday announced that its chief advocacy officer, John Fowler, has launched Session Garden, a cannabis-focused podcast. To view the full press release, visit http://cnw.fm/uOlE8. Also today, CannabisNewsWire released a report on the company detailing how SPRWF projects that its fiscal 2020 net revenues will increase to an estimated $150 million to $180 million, with a positive adjusted EBITDA. In FY2019, Supreme Cannabis reported net revenues of $41.8 million, including its first positive adjusted EBITDA quarter of $3.2 million (http://cnw.fm/yACv7).
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.6453, off by 7.8143%, on 663,263 volume with 444 trades. The average volume for the last 3 months is 481,623 and the stock's 52-week low/high is $0.6365/$1.7888.
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Chief Advocacy Officer Launches New Cannabis-Focused Podcast
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Projects Up to $180M in Net Revenues for FY2020
- Supreme Cannabis' John Fowler Launches New Podcast, Session Garden
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative DehydraTECH(TM) platform works to deliver chemical compounds to the bloodstream at speeds similar to inhalation methods, offering an alternative to smoking. To view the full press release, visit http://cnw.fm/4BvOd.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.
Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.
In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.
Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.
Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Friday's trading session at $0.61875, off by 7.6493%, on 39,441 volume with 44 trades. The average volume for the last 3 months is 79,718 and the stock's 52-week low/high is $0.399800002/$1.84000003.
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) DehydraTECH Platform Offers Alternative to Traditional Inhalation
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advances Innovation Research Through Agreement with Altria
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) DehydraTECH Featured in Human CBD Study Results Published in Clinical Journal
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology (NASDAQ: POAI), a developer of highly adaptable assessment methods for cancer patients to help guide personalized treatments, employs its proprietary smart tumor profiling and artificial intelligence (“AI”) platform to predict tumor drug response and improve clinical outcomes for cancer patients. To view the full article, visit http://nnw.fm/KaU2d.
Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Predictive Oncology (POAI), closed Friday's trading session at $0.414, off by 5.9091%, on 41,733 volume with 80 trades. The average volume for the last 3 months is 56,190 and the stock's 52-week low/high is $0.360000014/$0.850000023.
- Predictive Oncology Inc. (NASDAQ: POAI) Utilizing Artificial Intelligence, Smart Tumor Profiling to Augment Clinical Outcomes
- Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Takes Part in Groundbreaking Genomes Project
- Predictive Oncology Inc. (NASDAQ: POAI) Inks its Largest Single-Hospital Sale of Revolutionary STREAMWAY(R) System
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America (OTCQB: MCOA) was featured today in a publication from CBDWire, examining how cannabidiol (CBD) use has been on the rise this decade, with more and more people turning to the cannabinoid to help manage their ailments. It would be an understatement to say this compound is versatile.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Friday's trading session at $0.305, off by 18.0108%, on 2,067,450 volume with 683 trades. The average volume for the last 3 months is 228,990 and the stock's 52-week low/high is $0.023/$2.10599994.
- Cannabidiol Could Boost Effectiveness of Antibiotics, Study Finds
- 420 with CNW – Nearly a Thousand Businesses Sign Letter Asking Congress to Deschedule Marijuana
- Global CBD Prices Reduce as US Supply Shakes the Market
Nightfood Holdings, Inc. (OTCQB: NGTF)
Nightfood Holdings (OTCQB: NGTF), the innovative company addressing America’s $50 billion annual night snacking spend, today announced that it has scheduled an investor conference call, slated to take place at 4:30 PM ET on Thursday, October 24, 2019. To view the full press release, visit http://nnw.fm/ygXX2.
Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.
Nightfood Ice Cream
Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.
Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.
With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.
Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.
More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.
Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.
Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.
Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.
Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.
MJ Munchies, Inc.
MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.
Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.
Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.
Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.
CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.
The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.
Nightfood Holdings, Inc. (NGTF), closed Friday's trading session at $0.26, off by 2.731%, on 63,787 volume with 30 trades. The average volume for the last 3 months is 147,387 and the stock's 52-week low/high is $0.160099998/$0.920000016.
- Nightfood Holdings Inc. (NGTF) Schedules October 24 Investor Conference Call
- Nightfood Ice Cream Secures Initial Hotel Placements Through National Distribution Partner; J.D. Power Research Suggests Opportunity
- Nightfood Announces Distribution in Harris Teeter Supermarkets, Adding Over 250 Stores Throughout the Southeast and Mid-Atlantic Regions
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) is making a name for itself as a market leader while the global hemp-derived CBD oil market is projected to reach $22 billion by 2022 (http://cnw.fm/dTe3n). To view the full article, visit http://cnw.fm/1iQ73. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. California has made it easy for weed workers to join labor unions after Governor Gavin Newsom on Friday signed into law a bill that requires all cannabis stores that have 20 employees or more to enter into labor peace agreements.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Friday's trading session at $0.2163, off by 3.4375%, on 14,200 volume with 5 trades. The average volume for the last 3 months is 12,249 and the stock's 52-week low/high is $0.209000006/$0.797900021.
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Establishing Leadership in Booming Hemp-Derived, CBD-Oil Market
- 420 with CNW – California Marijuana Industry Workers Move to Unionize
- Iowa Parents Struggle to Find Doctors to Recommend Cannabidiol
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)
Petroteq Energy Inc. (TSXV:PQE; OTC:PQEFF; FSE: PQCF), a fully integrated surface oil sands mining oil company with proprietary technology, announces a final closing of its previously announced (September 17, 2019) equity financing at US$0.18. The Company raised gross proceeds of US$500,000 through the issuance of 2,777,777 units at US$0.18 per unit, with each unit consisting of one common share of the Company, and one share purchase warrant, with each warrant entitling the holder thereof to acquire an additional common share at US$0.23 per share for 24 months.
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.
Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.
The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.
The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.
The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.
Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.
“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.
In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.
“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.
Petroteq Energy Inc. (PQEFF), closed Friday's trading session at $0.1817, off by 3.6585%, on 274,455 volume with 46 trades. The average volume for the last 3 months is 230,052 and the stock's 52-week low/high is $0.112099997/$0.819999992.
- Petroteq Announces Closing of Financings
- Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Completes Maintenance, Resumes Production at Asphalt Ridge
- Facility Upgrades Strengthen Petroteq Energy Inc.’s (TSX.V: PQE) (OTC: PQEFF) Ability to Employ Clean Oil Recovery Technology
Endonovo Therapeutics Inc. (ENDV)
Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.
In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.
SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?
Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.
Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.
Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.
Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?
Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.
Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.
Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.
David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.
Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.
Endonovo Therapeutics Inc. (ENDV), closed Friday's trading session at $0.009, off by 5.2632%, on 2,979,704 volume with 47 trades. The average volume for the last 3 months is 4,413,961 and the stock's 52-week low/high is $0.006/$0.048999998.
- Foot Specialist’s Testimonial About Surgery Highlights Non-Opioid Pain Therapy of Endonovo Therapeutics Inc. (ENDV) Device
- Endonovo Therapeutics Inc. (ENDV) Expanding Commercialization of Wearable Pain-Management Device
- Endonovo Therapeutics Inc. (ENDV) Expanding Commercialization of SofPulse Pain Management Solution as Alternative to Opioids
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Becomes Fully Reporting with the SEC
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Opens Learning Center Featuring Augmented Reality Games, Educational Content
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Featured in Broadcast Discussing California’s Cannabis Industry
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Receives Milestone Health Canada Licence Amendment
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – Marijuana Will be Legalized this Month, Says Mexican Senate Leader
- ChineseInvestors.com (CIIX) Achieves Record Revenues for Q1 Fiscal Year 2020
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Names New CFO; Announces Private Placement, Equity Issuances
- CloudCommerce (OTCQB: CLWD) Inks Marketing Contract with Insurance Powerhouse Starr Insurance Companies
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Dama Financial - Provides Access to Transparent Banking Services for Cannabis Industry
- Earth Science Tech, Inc. (ETST) West Virginia Hemp Farmers Unhappy With THC Testing Protocol
- Endonovo Therapeutics (OTCQB: ENDV) Expanding Commercialization of SofPulse Pain Management Solution as Alternative to Opioids
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Inaugural MicroCap Rodeo Investor Conference
- Geyser Brands Inc. (TSX.V: GYSR) Investor Ideas Potcasts, Cannabis News and Stocks on the Move: Happy 1 Year Anniversary Canada
- GP Solutions (GWPD) Trading to Recommence October 17, 2019
- Grapefruit Boulevard Investments Inc. (IGNG) Key Requirements for Starting a Successful CBD Brand
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) CBD Products Like Topicals and Skincare Options Creating Partnership Opportunities in Retail
- Green Hygienics Holdings Inc. (GRYN) Hemp Pollen Researchers Get USDA Grant
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Announces Repricing of “Bought Deal” Brokered Private Placement
- InsuraGuest Inc. - Increases Reach to Include Europe through Landmark LOI
- INmune Bio, Inc. (NASDAQ: INMB) to Present at Advances in Immuno-Oncology USA Congress and at World Immunotherapy Congress in October
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Capitalizing on Adult-Use Cannabis Industry by Anticipating Market Movement
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Advances Innovation Research Through Agreement with Altria
- Marijuana Company of America Inc. (MCOA) 420 with CNW – Nearly a Thousand Businesses Sign Letter Asking Congress to Deschedule Marijuana
- MustGrow Biologics Corp (CSE: MGRO) Finalizes Liquid Formulation of Mustard-Derived Bio-Pesticide
- Neutra Corp. (OTCQB: NTRR) to Release Hemp-Based VIVIS Skin Cream
- Nightfood, Inc. (OTCQB: NGTF) AIce Cream Secures Initial Hotel Placements Through National Distribution Partner; J.D. Power Research Suggests Opportunity
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Canada Legalizes Marijuana Derivatives Today: 6 Things You Need to Know
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Opportunity Research Report Issued by Goldman Small Cap Research
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Completes Maintenance, Resumes Production at Asphalt Ridge
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Launches Top-Selling Edibles into Thriving Nevada Adult-Use Cannabis Market
- Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Takes Part in Groundbreaking Genomes Project
- Pressure BioSciences Inc. (PBIO) Proprietary PCT Platform Demonstrates Ability to Discover Cancer Biomarkers in Independent Research
- Quest Patent Research Corp. (QPRC) Subsidiary Alleges Patent Infringement by Apple Inc.
- Sharing Services Global Corporation (SHRG) Announces Record Q1 Revenues, Cumulative Sales of $129M
- SinglePoint, Inc. (SING) Featured on MoneyTV Focusing on Pure Hemp Cigarette Marketing Strategy
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Leading Taxi Technology Distributor Increases Purchase Order to Over $850,000
- Spectrum Global Solutions, Inc. (SGSI) Secures $3.3M in New 5G Prep Contracts
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – ACLU Sues County in Pennsylvania over Medical Marijuana
- SRAX Inc. (NASDAQ: SRAX) CEO to be Interviewed by The Wall Street Resource
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Installs Final Modules of “LiSTR” Direct Lithium Extraction Demonstration Plant at Arkansas Project Site
- Sugarmade, Inc. (SGMD) Wisconsin Senate Passes Hemp Bill
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) John Fowler Launches New Podcast, Session Garden
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) 420 with CNW – Former FDA Boss Calls for Federal Regulation of Marijuana Markets
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Green Light Documentary Predicts CBD Products Will Be Common Like Vitamin Pills
- Trxade Group Inc. (TRXD) Presents Appealing Profile in Recent Pharmaceutical Services Industry Analysis
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans
- VPR Brands, LP (VPRB) CEO Purchases Significant Personal Shares in Company
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Iowa Parents Struggle to Find Doctors to Recommend Cannabidiol
- Willow Biosciences Inc. (CSE: WLLW) Iowa Parents Struggle to Find Doctors to Recommend Cannabidiol
- Xalles Holdings Inc. (XALL) Enters Cryptocurrency Distribution Agreement as Fiat Money Faces Bleak Outlook
- Youngevity International, Inc. (NASDAQ: YGYI) Signs Letter of Intent with BeneYOU, LLC
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.